Children’s Cancer and Blood Disorders program achieves outcomes that rank among the top national programs and cares for more than two-thirds of Minnesota children and adolescents with blood disorders. Care for sickle cell disease and hemoglobinopathies is provided through a division of the Cancer and Blood Disorders program called Children’s hemoglobinopathy and sickle cell program. Through this program, families have access to the newest and most promising treatments and receive care spearheaded and coordinated by a board-certified hematologist/oncologist.

The Hemoglobinopathy and Sickle Cell Program at Children’s aims to address each patient’s specific needs. Through a multidisciplinary health care team, access to the most current diagnostic tools like Transcranial Doppler (technology used to help identify and prevent strokes in children and teens with sickle cell disease), the specially designed C.H. Robinson Infusion Center, preventative therapies, and groundbreaking clinical research, the Children’s program is unlike any other treatment option in the region.